13F Pro

SEC Form 4 reporting owner

Myles David C.

Myles David C. has filed 13 Form 4 transactions reported between December 19, 2025 and February 2, 2026, as CH. DISCOV. & NON-CLIN DEV OFF of Olema Pharmaceuticals, Inc..

Name as filed: Myles David C.

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$4.7M
8 lines
Companies
1
with Form 4 filings
Latest transaction
Feb 2, 2026
transaction date

Roles and reported holdings

  • OLMAOlema Pharmaceuticals, Inc.
    Dec 19, 2025 – Feb 2, 2026

    CH. DISCOV. & NON-CLIN DEV OFF

    Held directly542,761 sh as of Jan 14, 2026 · Form 4
    Held indirectly (latest line)144,846 sh as of Jan 12, 2026 · Form 4

    24 months: $4.7M sold

Transaction history

All 13 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Feb 2, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFGrant or awardCode A · direct106,250—Form 4
Feb 2, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFGrant or awardCode A · direct250,000—Form 4
Jan 14, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct35,003$1.0M@ $28.99Form 4
Jan 14, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct14,997$429K@ $28.60Form 4
Jan 14, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOption exerciseCode M · direct50,000$244K@ $4.87Form 4
Jan 13, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct200$6K@ $28.49Form 4
Jan 13, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct49,800$1.4M@ $27.60Form 4
Jan 13, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOption exerciseCode M · direct50,000$244K@ $4.87Form 4
Jan 12, 2026OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · indirect10,000$283K@ $28.34Form 4
Dec 19, 2025OLMACH. DISCOV. & NON-CLIN DEV OFFGiftCode G · direct9,000—Form 4
Dec 19, 2025OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct6,046$190K@ $31.39Form 4
Dec 19, 2025OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct43,729$1.3M@ $30.40Form 4
Dec 19, 2025OLMACH. DISCOV. & NON-CLIN DEV OFFOpen-market saleCode S · direct1,225$34K@ $28.08Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.